Position in PFE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$399,361,911
-$58,371,011 QoQ
Shares Held
16,584,797
+1.7% QoQ
Ownership
0.291%
of shares outstanding
% of Portfolio
0.25%
of 13F equity value
Holder Rank
#39
of 2,816 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026VAN ECK ASSOCIATES CORP holds $2,307,026,460 across 15 Drug Manufacturers - General names. PFE ranks #3 (17.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BMY |
Bristol Myers Squibb Co
|
10,217,590 | $588,737,534 | |
| 2 | LLY |
ELI LILLY & Co
|
344,960 | $413,755,406 | |
| 3 | PFE |
Pfizer Inc
This page
|
16,584,797 | $399,361,911 | |
| 4 | MRK |
Merck & Co., Inc.
|
1,370,439 | $176,101,411 | |
| 5 | JNJ |
Johnson & Johnson
|
644,520 | $163,688,742 | |
| 6 | AZN |
Astrazeneca PLC
|
558,835 | $105,966,291 | |
| 7 | NVS |
Novartis AG
|
633,523 | $99,285,724 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
716,459 | $90,517,428 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $399,361,911 | 16,584,797 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $457,732,922 | 16,301,030 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $332,234,723 | 13,342,760 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $462,628,639 | 18,156,540 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $555,121,184 | 22,901,039 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $560,156,309 | 22,105,616 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $564,738,935 | 21,286,805 | Shares | Defined | 2025-01-29 | |
| 2024-09-30 | $479,253,807 | 16,560,256 | Shares | Defined | 2024-10-29 | |
| 2024-06-30 | $450,592,381 | 16,104,088 | Shares | Defined | 2024-07-31 | |
| 2024-03-31 | $438,819,851 | 15,813,328 | Shares | Sole | 2024-04-30 | |
| 2023-12-31 | $373,813,677 | 12,984,150 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $322,375,049 | 9,718,874 | Shares | Defined | 2023-11-08 | |
| 2023-06-30 | $273,104,571 | 7,445,599 | Shares | Defined | 2023-08-03 | |
| 2023-03-31 | $156,838,055 | 3,844,070 | Shares | Defined | 2023-05-03 | |
| 2022-12-31 | $77,737,227 | 1,517,120 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $66,342,697 | 1,516,058 | Shares | Sole | 2022-10-27 | |
| 2022-06-30 | $68,582,056 | 1,308,069 | Shares | Sole | 2022-08-03 | |
| 2022-03-31 | $23,587,343 | 455,618 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $28,762,781 | 487,092 | Shares | Sole | 2022-01-26 | |
| 2021-09-30 | $127,449,080 | 2,963,243 | Shares | Sole | 2021-11-03 | |
| 2021-06-30 | $189,596,546 | 4,841,587 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $169,077,366 | 4,666,778 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $125,715,204 | 3,415,246 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $123,846,596 | 3,374,570 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $104,561,038 | 3,197,582 | Shares | Defined | 2020-08-10 | |
| 2020-03-31 | $92,609,998 | 2,837,320 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||